Study points way to potential new treatment for brittle bone disease
By Ruth SoRelle, M.P.H. Patients with osteogenesis imperfecta (brittle bone disease) treated with teriparatide, a form of parathyroid hormone approved for treatment of women with osteoporosis,
Read More